Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR)

SIMPLE SUMMARY: The monitoring of the minimal residual disease (MRD) in Chronic Myeloid Leukemia is a key element in the management of affected patients because it reflects the response to therapy and allows for the selection of the best responders who may benefit from the suspension of the therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Abruzzese, Elisabetta, Bocchia, Monica, Trawinska, Malgorzata Monika, Raspadori, Donatella, Bondanini, Francesco, Sicuranza, Anna, Pacelli, Paola, Re, Federica, Cavalleri, Alessia, Farina, Mirko, Malagola, Michele, Russo, Domenico, De Fabritiis, Paolo, Bernardi, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452239/
https://www.ncbi.nlm.nih.gov/pubmed/37627140
http://dx.doi.org/10.3390/cancers15164112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452239/
https://www.ncbi.nlm.nih.gov/pubmed/37627140
http://dx.doi.org/10.3390/cancers15164112

Ejemplares similares